AURQF yields 133333.33% · PFE yields 6.13%● Live data
📍 AURQF pulled ahead of the other in Year 1
Combined, AURQF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AURQF + PFE for your $10,000?
Aurelius Minerals Inc., an exploration stage company, engages in acquisition, exploration, and evaluation of mineral properties in Canada. The company explores for gold. It holds a 100% interest in the Lipton property with 57 claims covering an area of approximately 12,425 hectares; and the Mikwam property with 69 cell claims covering an area of approximately 968 hectares located within the northern Abitibi Gold Belt in Ontario. The company also holds interests in the Aureus gold properties, including Aureus West and East with 104 mineral claims covering an area of approximately 1,684 hectares in Abitibi Greenstone Belt in Ontario; the Tangier gold project; and the Forest Hill Gold project comprise 115 contiguous mineral exploration claims in four exploration licenses with an aggregate area of 1,840 hectares. The company was formerly known as Galena International Resources Ltd. and changed its name to Aurelius Minerals Inc. in January 2017. Aurelius Minerals Inc. was incorporated in 2007 and is based in Toronto, Canada.
Full AURQF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.